Adipocytes express a functional system for serotonin synthesis, reuptake and receptor activation

Diabetes, Obesity and Metabolism

Volumn 13, Issue 6, 2011, Pages 551-558

  Stunes, A K ^a   Reseland, J E ^b   Hauso, O ^a,c   Kidd, M ^d   Tommeras K ^a   Waldum, H L ^a,c   Syversen, U ^a,c   Gustafsson, B I ^a,c  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adipocytes; Adipose tissue; Leptin; Serotonin; Serotonin receptors

Indexed keywords

GHRELIN; LEPTIN; MESSENGER RNA; SEROTONIN; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER; SODIUM CHLORIDE;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; INTRAABDOMINAL FAT; MESENCHYME CELL; NONHUMAN; PLASMA; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RAT; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROTONIN UPTAKE;

EID: 79955039894     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2011.01378.x     Document Type: Article

References (42)

1. Hoyer D, Hannon JP, Martin GR. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 2002; 71: 533-554.
2. Siddiqui EJ, Thompson CS, Mikhailidis DP, Mumtaz FH. The role of serotonin in tumour growth (review). Oncol Rep 2005; 14: 1593-1597.
3. Frishman WH, Huberfeld S, Okin S, Wang YH, Kumar A, Shareef B. Serotonin and serotonin antagonism in cardiovascular and non-cardiovascular disease. J Clin Pharmacol 1995; 35: 541-572.
4. Gershon MD. Review article: roles played by 5-hydroxytryptamine in the physiology of the bowel. Aliment Pharmacol Ther 1999; 13(Suppl. 2): 15-30.
5. Aronne LJ, Thornton-Jones ZD. New targets for obesity pharmacotherapy. Clin Pharmacol Ther 2007; 81: 748-752.
6. Halford JC, Harrold JA, Boyland EJ, Lawton CL, Blundell JE. Serotonergic drugs: effects on appetite expression and use for the treatment of obesity. Drugs 2007; 67: 27-55.
7. Heisler LK, Jobst EE, Sutton GM et al. Serotonin reciprocally regulates melanocortin neurons to modulate food intake. Neuron 2006; 51: 239-249.
8. Hoyer D, Clarke DE, Fozard JR et al. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 1994; 46: 157-203.
9. Lesurtel M, Graf R, Aleil B et al. Platelet-derived serotonin mediates liver regeneration. Science 2006; 312: 104-107.
10. Nocito A, Georgiev P, Dahm F et al. Platelets and platelet-derived serotonin promote tissue repair after normothermic hepatic ischemia in mice. Hepatology 2007; 45: 369-376.
11. Takuwa N, Ganz M, Takuwa Y, Sterzel RB, Rasmussen H. Studies of the mitogenic effect of serotonin in rat renal mesangial cells. Am J Physiol 1989; 257(3 Pt 2): F431-F439.
12. Nemecek GM, Coughlin SR, Handley DA, Moskowitz MA. Stimulation of aortic smooth muscle cell mitogenesis by serotonin. Proc Natl Acad Sci U S A 1986; 83: 674-678.
13. Seuwen K, Magnaldo I, Pouyssegur J. Serotonin stimulates DNA synthesis in fibroblasts acting through 5-HT1B receptors coupled to a Gi-protein. Nature 1988; 335: 254-256.
14. Pakala R, Willerson JT, Benedict CR. Mitogenic effect of serotonin on vascular endothelial cells. Circulation 1994; 90: 1919-1926.
15. Gustafsson BI, Thommesen L, Stunes AK et al. Serotonin and fluoxetine modulate bone cell function in vitro. J Cell Biochem 2006; 98: 139-151.
16. Westbroek I, van der Plas A, de Rooij KE, Klein-Nulend J, Nijweide PJ. Expression of serotonin receptors in bone. J Biol Chem 2001; 276: 28961-2898.
17. Battaglino R, Fu J, Spate U et al. Serotonin regulates osteoclast differentiation through its transporter. J Bone Miner Res 2004; 19: 1420-1431.
18. Bliziotes MM, Eshleman AJ, Zhang XW, Wiren KM. Neurotransmitter action in osteoblasts: expression of a functional system for serotonin receptor activation and reuptake. Bone 2001; 29: 477-486.
19. Valassi E, Scacchi M, Cavagnini F. Neuroendocrine control of food intake. Nutr Metab Cardiovasc Dis 2008; 18: 158-168.
20. Shimizu K, Sakai M, Ando M et al. Newly developed primary culture of rat visceral adipocytes and their in vitro characteristics. Cell Biol Int 2006; 30: 381-388.
21. Benito M, Porras A, Nebreda AR, Santos E. Differentiation of 3T3-L1 fibroblasts to adipocytes induced by transfection of ras oncogenes. Science 1991; 253: 565-568.
22. Penney DP, Powers JM, Frank M, Willis C, Churukian C. Analysis and testing of biological stains-the Biological Stain Commission Procedures. Biotech Histochem 2002; 77: 237-275.
23. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
24. Gustafsson BI, Tommeras K, Nordrum I et al. Long-term serotonin administration induces heart valve disease in rats. Circulation 2005; 111: 1517-1522.
25. Gustafsson BI, Westbroek I, Waarsing JH et al. Long-term serotonin administration leads to higher bone mineral density, affects bone architecture, and leads to higher femoral bone stiffness in rats. J Cell Biochem 2006; 97: 1283-1291.
26. Shi Y, Burn P. Lipid metabolic enzymes: emerging drug targets for the treatment of obesity. Nat Rev Drug Discov 2004; 3: 695-710.
27. Hardebo JE, Owman C. Barrier mechanisms for neurotransmitter monoamines and their precursors at the blood-brain interface. Ann Neurol 1980; 8: 1-31.
28. Tecott LH, Sun LM, Akana SF et al. Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature 1995; 374: 542-546.
29. Vickers SP, Dourish CT, Kennett GA. Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors. Neuropharmacology 2001; 41: 200-209.
30. Halaas JL, Gajiwala KS, Maffei M et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269: 543-546.
31. Klok MD, Jakobsdottir S, Drent ML. The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review. Obes Rev 2007; 8: 21-34.
32. Calapai G, Corica F, Corsonello A et al. Leptin increases serotonin turnover by inhibition of brain nitric oxide synthesis. J Clin Invest 1999; 104: 975-982.
33. Linder K, Arner P, Flores-Morales A, Tollet-Egnell P, Norstedt G. Differentially expressed genes in visceral or subcutaneous adipose tissue of obese men and women. J Lipid Res 2004; 45: 148-154.
34. Schaffler A, Scholmerich J, Buchler C. Mechanisms of disease: adipocytokines and visceral adipose tissue-emerging role in intestinal and mesenteric diseases. Nat Clin Pract Gastroenterol Hepatol 2005; 2: 103-111.
35. Atzmon G, Yang XM, Muzumdar R, Ma XH, Gabriely I, Barzilai N. Differential gene expression between visceral and subcutaneous fat depots. Horm Metab Res 2002; 34: 622-628.
36. Poussin C, Hall D, Minehira K, Galzin AM, Tarussio D, Thorens B. Different transcriptional control of metabolism and extracellular matrix in visceral and subcutaneous fat of obese and rimonabant treated mice. PLoS One 2008; 3: e3385.
37. Barbu A, Hedlund GP, Lind J, Carlsson C. Pref-1 and adipokine expression in adipose tissues of GK and Zucker rats. Mol Cell Endocrinol 2009; 299: 163-171.
38. Yamada J, Sugimoto Y, Ujikawa M. The serotonin precursor 5-hydroxytryptophan elevates serum leptin levels in mice. Eur J Pharmacol 1999; 383: 49-51.
39. Yamada J, Ujikawa M, Sugimoto Y. Serum leptin levels after central and systemic injection of a serotonin precursor, 5-hydroxytryptophan, in mice. Eur J Pharmacol 2000; 406: 159-162.
40. Leibowitz SF, Alexander JT. Hypothalamic serotonin in control of eating behavior, meal size, and body weight. Biol Psychiatry 1998; 44: 851-864.
41. Telles MM, Guimaraes RB, Ribeiro EB. Effect of leptin on the acute feeding-induced hypothalamic serotonergic stimulation in normal rats. Regul Pept 2003; 115: 11-18.
42. Uchida-Kitajima S, Yamauchi T, Takashina Y et al. 5-Hydroxytryptamine 2A receptor signaling cascade modulates adiponectin and plasminogen activator inhibitor 1 expression in adipose tissue. FEBS Lett 2008; 582: 3037-3044.